期刊
NATURE
卷 569, 期 7758, 页码 723-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41586-019-1173-8
关键词
-
资金
- Marsha Rivkin Foundation
- National Cancer Institute (NCI) [CA111882, CA211916]
- Arthur L. and Lee G. Herbst Professorship
- NIH [CA175399, DP2GM128199]
- V Foundation for Cancer Research [V2016-020]
- Korber Foundation
- Max-Planck Society for the Advancement of Science
- Novo Nordisk Foundation [NNF14CC0001, NNF15CC0001]
- University of Chicago Cancer Center Support Grant [P30CA014599]
- Ludwig Institute for Cancer Research
High-grade serous carcinoma has a poor prognosis, owing primarily to its early dissemination throughout the abdominal cavity. Genomic and proteomic approaches have provided snapshots of the proteogenomics of ovarian cancer(1,2), but a systematic examination of both the tumour and stromal compartments is critical in understanding ovarian cancer metastasis. Here we develop a label-free proteomic workflow to analyse as few as 5,000 formalin-fixed, paraffin-embedded cells microdissected from each compartment. The tumour proteome was stable during progression from in situ lesions to metastatic disease; however, the metastasis-associated stroma was characterized by a highly conserved proteomic signature, prominently including the methyltransferase nicotinamide N-methyltransferase (NNMT) and several of the proteins that it regulates. Stromal NNMT expression was necessary and sufficient for functional aspects of the cancer-associated fibroblast (CAF) phenotype, including the expression of CAF markers and the secretion of cytokines and oncogenic extracellular matrix. Stromal NNMT expression supported ovarian cancer migration, proliferation and in vivo growth and metastasis. Expression of NNMT in CAFs led to depletion of S-adenosyl methionine and reduction in histone methylation associated with widespread gene expression changes in the tumour stroma. This work supports the use of ultra-low-input proteomics to identify candidate drivers of disease phenotypes. NNMT is a central, metabolic regulator of CAF differentiation and cancer progression in the stroma that may be therapeutically targeted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据